Found 19 matching trials
Study of Paclitaxel in Patients With Ovarian Cancer PHASE3 RATIONALE: Paclitaxel is one of the most widely used human anticancer agent...
Show More Location
Gomel Regional Clincial Oncology Center
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer PHASE1 Dose-dense paclitaxel (Genexol®-PM) once a week in combination with carbopl...
Show More Location
Samyang Biopharmaceuticals
Learn More & Join Trial
TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma PHASE2 The NCCN guidelines recommend induction chemotherapy followed by concurrent...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Role of Kefir Mouth Wash in Oral Health Status Amelioration PHASE2 The present research aims to evaluate the efficiency of kefir mouthwash in ...
Show More Location
Al-Mustansiriyah University/College of Dentistry
Learn More & Join Trial
Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer PHASE3 This is a phase-3, open-label, multicenter, two-arm treatment study to eval...
Show More Location
Multiple Locations
Learn More & Join Trial
CYCLosporinE A in Reperfused Acute Myocardial Infarction PHASE3 Infarct size is a major determinant of prognosis after myocardial infarctio...
Show More Location
Ospedale Regionale Umberto Parini
Learn More & Join Trial
A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers PHASE1 To compare the bioavailability, pharmacokinetic profiles and the tolerabili...
Show More Learn More & Join Trial
Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis PHASE2 This study is designed to confirm the safety of the proposed dose and sched...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer PHASE1 This is a phase I/II trial to determine the maximum tolerated dose and reco...
Show More Location
Multiple Locations
Learn More & Join Trial
ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer PHASE2 The anticancer agent paclitaxel (marketed as Taxol) has shown remarkable ac...
Show More Location
Abraxis BioScience, Inc.
Learn More & Join Trial